{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:03:40Z","timestamp":1776132220531,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21267"],"award-info":[{"award-number":["21267"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["gr-2013-02358238"],"award-info":[{"award-number":["gr-2013-02358238"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02362631"],"award-info":[{"award-number":["GR-2016-02362631"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02362631"],"award-info":[{"award-number":["GR-2016-02362631"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/s41408-019-0179-7","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T13:17:08Z","timestamp":1549891028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Validation of the Mayo alliance prognostic system for mastocytosis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4810-6501","authenticated-orcid":false,"given":"Francesco","family":"Mannelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Gesullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Rotunno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Pacilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-284X","authenticated-orcid":false,"given":"Paola","family":"Guglielmelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5755-0730","authenticated-orcid":false,"given":"Alessandro M.","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"179_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent, P., Akin, C. & Metcalfe, D. D. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 129, 1420\u20131427 (2017).","journal-title":"Blood"},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ajh.24382","volume":"91","author":"L Pieri","year":"2016","unstructured":"Pieri, L. et al. Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients. Am. J. Hematol. 91, 692\u2013699 (2016).","journal-title":"Am. J. Hematol."},{"key":"179_CR4","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2013.119","volume":"27","author":"AM Vannucchi","year":"2013","unstructured":"Vannucchi, A. M. et al. Mutations and prognosis in primary myelofibrosis. Leukemia 27, 1861\u20131869 (2013).","journal-title":"Leukemia"},{"key":"179_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1200\/JCO.2017.76.4886","volume":"36","author":"P Guglielmelli","year":"2018","unstructured":"Guglielmelli, P. et al. MIPSS70: mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis. J. Clin. Oncol. 36, 301\u2013318 (2018).","journal-title":"J. Clin. Oncol."},{"key":"179_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/ajh.24426","volume":"91","author":"A Pardanani","year":"2016","unstructured":"Pardanani, A. et al. Next-generation sequencing in systemic mastocytosis: derivation of a mutation-augmented clinical prognostic model for survival. Am. J. Hematol. 91, 888\u2013893 (2016).","journal-title":"Am. J. Hematol."},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/leu.2015.284","volume":"30","author":"M Jawhar","year":"2016","unstructured":"Jawhar, M. et al. Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(\u2009+\u2009) advanced systemic mastocytosis. Leukemia 30, 136\u2013143 (2016).","journal-title":"Leukemia"},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/bjh.13865","volume":"175","author":"AD Pardanani","year":"2016","unstructured":"Pardanani, A. D. et al. ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis. Br. J. Haematol. 175, 534\u2013536 (2016).","journal-title":"Br. J. Haematol."},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1182\/bloodadvances.2018026245","volume":"2","author":"A Pardanani","year":"2018","unstructured":"Pardanani, A. et al. Mayo alliance prognostic system (MAPS) for mastocytosis: clinical and hybrid clinical-molecular models. Blood Adv. 2, 2964\u20132972 (2018).","journal-title":"Blood Adv."},{"key":"179_CR10","doi-asserted-by":"publisher","first-page":"JCO2018789867","DOI":"10.1200\/JCO.2018.78.9867","volume":"36","author":"A Tefferi","year":"2018","unstructured":"Tefferi, A. et al. MIPSS70+Version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis. J. Clin. Oncol. 36, JCO2018789867 (2018).","journal-title":"J. Clin. Oncol."},{"key":"179_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/ajh.25265","volume":"93","author":"S Shah","year":"2018","unstructured":"Shah, S. et al. Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.Am. J. Hematol. 93, 1461\u20131466 (2018).","journal-title":"Am. J. Hematol."},{"key":"179_CR12","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","volume":"374","author":"J Gotlib","year":"2016","unstructured":"Gotlib, J. et al. Efficacy and safety of midostaurin in advanced systemic mastocytosis. New Engl. J. Med. 374, 2530\u20132541 (2016).","journal-title":"New Engl. J. Med."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0179-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0179-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0179-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:09:45Z","timestamp":1671206985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-019-0179-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1038\/s41408-019-0179-7","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"13 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"18"}}